Functional aspects of iscoms

Immunology and Cell Biology

Volumn 76, Issue 4, 1998, Pages 295-299

  Morein, Bror ^a   Bengtsson, Karin Lövgren ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Adjuvant; Cytotoxic T cells; Immune modulation; Immune targeting; Iscom; Mucosal immunity; Neonatal immunity; T cells; T helper cells; Vaccine

Indexed keywords

ISCOM;

ANTIBODY RESPONSE; CYTOTOXIC T LYMPHOCYTE; DRUG DELIVERY SYSTEM; FUNCTIONAL ASSESSMENT; GENE TARGETING; HELPER CELL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; NONHUMAN; REVIEW; STOMACH MUCOSA; T LYMPHOCYTE ACTIVATION;

ANIMALS; HUMANS; IMMUNITY, MUCOSAL; ISCOMS; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; TH2 CELLS;

EID: 0031877659     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1998.00756.x     Document Type: Review

References (29)

1. Morein B, Lövgren Bengtsson K, Cox J. Modern adjuvants. Functional aspects. In: Kaufmann SHE (ed.) Concepts in Vaccine Development. Berlin: Walter de Gruyter, 1996; 243-63.
2. Morein B, Helenius A, Simons K, Pettersson R, Kääriäinen L, Shirrmacher V. Effective subunit vaccines against an enveloped animal virus. Nature 1978; 276: 715-18.
3. Adams SE, Kingsman AJ. Retrovirus and retrotransposon particles as antigen presentation and delivery systems. In: Powell, Newman (eds) Vaccine Design: The Subunit and Adjuvant Approach. New York: Plenum Press, 1995; 769-802
4. Morein B, Lövgren K, Rönnberg B, Sjölander A and Villacrés-Eriksson M. Immunostimulating complexes: clinical potential in vaccine development. Clin. Immunother. 1995; 3: 461-475.
5. Lövgren-Bengtsson K. Preparation and use of adjuvants. In: Kaufman SHE (ed.), Methods in Microbiology, vol. 25. Academic Press, 1998.
6. Sjölander A, Lövgren K, Hansson M, Wåhlin B, Berzins K, Perlmann P. Immunogenicity in rabbits and monkeys of influenza iscoms conjugated with repeated sequences of the Plasmodium falciparum antigen PF155/RESA. Parasite Immunol. 1993; 15: 355-9.
7. Larsson M, Lövgren K, Morein B. Immunopotentiation of synthetic oligopeptides by chemical conjugation to iscoms. J. Immunol. Meth. 1993; 162: 257-60.
8. O'Hagan DT. Microparticles as oral vaccines. In: O'Hagan DT (ed.) Novel Delivery Systems for Oral Vaccines. Ann Arbor: CRC press, 1994; 175-205.
9. Watson DL, Watson NA, Fossum C, Lövgren K, Morein B. Interactions between immune-stimulating complexes (iscoms) and peritoneal mononuclear leucocytes. Microbiol. Immunol. 1992; 36: 199-203.
10. Villacres MC, Behboudi S, Nikkila T, Lövgren-Bengtsson K, Morein B. Internalization of iscom-borne antigens and presentation under MHC class I or class II cellular immunology. Cell. Immunol. 1998; 185: 30-8.
11. Deres K, Schild H, Wiesmuller KH, Jung G, Rammensee HG. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 1989; 342: 561-4.
12. Morein B, Barz D, Koszinowski U, Schirrmacher V. Integration of a virus membrane protein into the lipid bilayer of target cells as a prerequisite for immune cytolysis: Specific cytolysis alter virosome-target cell fusion. J. Exp. Med. 1979; 150: 1383-98.
13. Villacres-Eriksson M, Behboudi S, Morgan AJ, Trinchieri G, Morein B. Immunomodulation by Quillaja saponaria adjuvant formulations: In vivo stimulation of interleukin 12 and its effects on the antibody response. Cytokine 1997; 9: 73-82.
14. Behboudi S, Morein B, Villacres-Eriksson M. In vitro activation of antigen-presenting cells (APC) by defined composition of Quillaja saponaria Molina triterpenoids. Clin. Exp. Immunol. 1996; 105: 26-30.
15. Behboudi S, Morein B, Villacres-Eriksson M. In vivo and in vitro induction of IL-6 by Quillaja saponaria Molina triterpenoid formulations. Cytokine 1997; 9: 682-7.
16. Heeney JL, van Gils ME, van der Heide P et al. The role of type-1 and type-2 T-helper immune responses and HIV-1 protection. J. Med. Primat. (in press).
17. Davis D, Morein B, Åkerblom L et a. A recombinant prime, peptide boost vaccination strategy can focus the immune response on to more than one epitope even though these may not be immunodominant in the complex immunogen. Vaccine 1997; 15: 1661-9.
18. Kovacsvics-Bankowski M, Rock KL. A phagosome-to-cytosol pathway for ecogenous antigens presented on MHC Class I molecules. Science 1995; 267: 243-6.
19. Takahashi H, Takeshita T, Morein B, Putney S, Germain RN, Berzofsky J. Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in iscoms. Nature 1990; 344: 873-5.
20. Dotsika E, Karagouni E, Sundquist B, Morein B, Morgan A, Villacrés-Eriksson M. Influence of Quillaja saponaria triterpenoid content on the immunomodulatory capacity of Epstein-Barr virus (EBV) iscoms. Scand. J. Immunol. 1997; 45: 261-8.
21. Holmgren J, Czerkinsky C, Sun J-B, Svennerholm A-M. Oral vaccination, mucosul immunity and oral tolerance with special reference to cholera toxin. In: Kaufmann SHE (ed.) Concepts in Vaccine Development. Berlin: Walter de Gruyter, 1996; 437-58.
22. Ekström J, Hu K-F, Lövgren-Bengtsson K, Morein B. Iscom and iscom matrix enhance by intranasal route the IgA response to OVA and rCTB in local and remote mucosal secretions. Vaccine 1998; (in press).
23. Mowat A McI, Viney JL. The anatomical basis of intestinal immunity. Immunol. Rev. 1997; 156: 145.
24. Adkins B, Chun K, Hamilton K, Nassiri M. Naive murine neonatal T cells undergo apoptosis in response to primary stimulation. J. Immunol. 1996; 157: 1343-9.
25. Barrios C, Brawand P, Berney M, Brandt C, Lambert P-H, Siegrist C-A. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: Predominance of a Th2-biased pattern which persists after adult boosting. Eur. J. Immunol. 1996; 26: 1489-96.
26. Marshall-Clarke S, Playfair JHL. B cells: Subpopulations, tolerance and autoimmunity. Immunol. Rev. 1979; 43: 109.
27. Ridge JP, Fuchs EJ, Matzinger P. Neonatal tolerance revisited: Turning on newborn T cells with dendritic cells. Science 1996; 271: 1723-6.
28. Nordengrahn A, Rusvai M, Merza M, Ekström J, Morein B, Belák S. Equine herpesvirus type 2 (EHV-2) as a predisposing factor for Rhodococcus equi pneumonia in foals: Prevention of the bifactorial disease with EHV-2 immunostimulating complexes. Vet. Microbiol. 1996; 51: 55-68.
29. Binnendijk RS van, Poelen MCM, Amerongen G van, Vried P de, Osterhaus ADME. Protective immunity in macaques vaccinated with live attenuated, recombinant and subunit measles vaccines in the presence of passively acquired antibodies. J. Inf. Dis. 1997; 175: 524-32.